Table 4.
Antimicrobial agents | Pooled estimates of resistant isolates (Proportion) | |||
---|---|---|---|---|
S. aureus | CoNS | |||
Pooled ES (95% CI) | I2 (%) | Pooled ES (95% CI) | I2 (%) | |
AMO | 0.69 (0.50, 0.87) | 97.64 | 0.62 (0.34, 0.90) | 93.05 |
AMC | 0.27 (0.16, 0.38) | 81.35 | NA | – |
AMP | 0.76 (0.60, 0.92) | 97.17 | 0.72 (0.57,0.87) | 70.85 |
CIP | 0.12 (0.08, 0.16) | 72.39 | 0.13 (0.04, 0.23) | 65.46 |
CRO | 0.36 (0.17, 0.55) | 97.23 | 0.37 (0.19, 0.54) | 81.58 |
SXT | 0.35 (0.20, 0.49) | 97.64 | 0.49 (0.31, 0.66) | 75.21 |
ERY | 0.34 (0.22, 0.46) | 94.69 | 0.40 (0.20, 0.40) | 90.05 |
GEN | 0.13 (0.08, 0.18) | 82.90 | 0.33 (0.17, 0.50) | 88.16 |
MET | 0.49 (0.31, 0.68) | 94.50 | NA | – |
AMO Amoxicillin, AMP Ampicillin, AMC Amoxicillin-clavulanic acid, SXT Cotrimoxazole, CRO Ceftriaxone, CIP Ciprofloxacin, GEN Gentamicin, MET Methicillin, ERY Erythromycin, NA Not analyzed: CoNS, Coagulase negative Staphylococci